Cargando…

Low health-related quality of life in hypoparathyroidism and need for PTH analog

OBJECTIVE: Hypoparathyroidism (HypoPT) is a rare endocrine disorder in which insufficient levels of parathyroid hormone (PTH) lead to low serum calcium (S-Ca) levels and muscular cramps. The aim was to study the health-related quality of life (HRQoL) and comorbidities in patients with HypoPT compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kontogeorgos, Georgios, Mamasoula, Zoi, Krantz, Emily, Trimpou, Penelope, Landin-Wilhelmsen, Kerstin, Laine, Christine M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789022/ https://www.ncbi.nlm.nih.gov/pubmed/34825891 http://dx.doi.org/10.1530/EC-21-0379

Ejemplares similares

Teriparatide treatment in severe osteoporosis – a controlled 10-year follow-up study
por: Kontogeorgos, Georgios, et al.
Publicado: (2022)

Normocalcaemic, vitamin D‐sufficient hyperparathyroidism – high prevalence and low morbidity in the general population: A long‐term follow‐up study, the WHO MONICA project, Gothenburg, Sweden
por: Kontogeorgos, Georgios, et al.
Publicado: (2015)

Health-Related Quality of Life in Turner Syndrome and the Influence of Growth Hormone Therapy: A 20-Year Follow-Up
por: Krantz, Emily, et al.
Publicado: (2019)

Comparison between different instruments for measuring health-related quality of life in a population sample, the WHO MONICA Project, Gothenburg, Sweden: an observational, cross-sectional study
por: Krantz, Emily, et al.
Publicado: (2019)

Comorbidity and quality of life in obesity–a comparative study with the general population in Gothenburg, Sweden
por: Mejaddam, Ala, et al.
Publicado: (2022)

Comorbidity and health-related quality of life in Somali women living in Sweden
por: Demeke, Taye, et al.
Publicado: (2019)

High androgen levels protect against hypothyroidism
por: Schmidt, Johanna, et al.
Publicado: (2016)

Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls
por: Forslund, Maria, et al.
Publicado: (2018)

Continuous rhPTH (1–34) treatment in chronic hypoparathyroidism
por: Fuss, Carmina Teresa, et al.
Publicado: (2020)

Hearing and Balance Exceed Initial Bone Mineral Density in Predicting Incident Fractures: A 25‐Year Prospective Observational Study in Menopausal Women With Osteoporosis
por: Dotevall, Annika, et al.
Publicado: (2021)

Use of rhPTH(1-84) for hypoparathyroidism during early pregnancy and lactation
por: Liao, E Pauline, et al.
Publicado: (2023)

Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long‐Acting PTH Analog (LA‐PTH)
por: Noda, Hiroshi, et al.
Publicado: (2020)

SAT-396 A Non-Surgical Animal Model of Hypoparathyroidism for Testing PTH Analogues
por: Ramezani-Pour, Narjes, et al.
Publicado: (2020)

Iodine Status After Bariatric Surgery—a Prospective 10-Year Report from the Swedish Obese Subjects (SOS) Study
por: Manousou, Sofia, et al.
Publicado: (2017)

OR07-03 Continuous Subcutaneous Delivery of RhPTH(1-84) by Pump in Adults with Hypoparathyroidism
por: Bove-Fenderson, Erin, et al.
Publicado: (2020)

Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1–84) treatment
por: Marcucci, G., et al.
Publicado: (2022)

SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransCon PTH, a Long-Acting PTH, in Patients With Hypoparathyroidism
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution
por: Forslund, M, et al.
Publicado: (2020)

Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up
por: Laine, C. M., et al.
Publicado: (2017)

Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1–84)
por: Chen, Kristina S, et al.
Publicado: (2020)

Desperate Times Call for Desperate Measures: Use of Continuous Subcutaneous 1-34 PTH Infusion for Postsurgical Hypoparathyroidism
por: Haider, Adnan, et al.
Publicado: (2021)

Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway
por: Astor, Marianne C., et al.
Publicado: (2016)

Correlation between iPTH Levels on the First Postoperative Day After Total Thyroidectomy and Permanent Hypoparathyroidism: Our Experience
por: Canu, Gian Luigi, et al.
Publicado: (2019)

Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
por: Saki, Forough, et al.
Publicado: (2020)

Subcutaneous Infusion of rhPTH(1-34) During Pregnancy and Nursing in a Woman With Autosomal Dominant Hypoparathyroidism 1
por: Shulman, Dorothy
Publicado: (2022)

Safety and Efficacy of PTH 1‐34 and 1‐84 Therapy in Chronic Hypoparathyroidism: A Meta‐Analysis of Prospective Trials
por: Puliani, Giulia, et al.
Publicado: (2022)

Postoperative Chronic Hypoparathyroidism and Quality of Life After Total Thyroidectomy
por: Jørgensen, Camilla Uhre, et al.
Publicado: (2021)

Short-Term PTH(1-34) Therapy in Children to Correct Severe Hypocalcemia and Hyperphosphatemia due to Hypoparathyroidism: Two Case Studies
por: Mishra, Pooja E., et al.
Publicado: (2016)

SAT-408 Bioactivity of Long Acting PTH Fusion Molecules Tested in a Novel Non-Surgical Animal Model of Hypoparathyroidism
por: Wilkinson, Ian R, et al.
Publicado: (2020)

Is it True Hypoparathyroidism? A Root Cause Analysis of Unusually Low Intact Parathyroid Hormone (iPTH) at a Clinical Laboratory
por: Ahmed, Sibtain, et al.
Publicado: (2021)

OR21-1 The PaTH Forward Trial: Efficacy and Safety of TransCon PTH Through Week 84 for Adults With Hypoparathyroidism
por: Ahmed, Intekhab, et al.
Publicado: (2022)

Effects of parathyroid hormone rhPTH(1–84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study
por: Clarke, Bart L., et al.
Publicado: (2016)

Serum Calcium Levels in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort
por: Rejnmark, Lars, et al.
Publicado: (2021)

PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism
por: Khan, Aliya A, et al.
Publicado: (2021)

Lower Risk of Cardiovascular Events in Adult Patients with Chronic Hypoparathyroidism Treated with rhPTH(1–84): A Retrospective Cohort Study
por: Ayodele, Olulade, et al.
Publicado: (2022)

ODP118 PTH (1-34) Replacement Therapy for Hypoparathyroidism due to Sporadic Calcium Sensing Receptor Gain-of-Function Point Mutation
por: Basina, Marina, et al.
Publicado: (2022)

Do we need sick-day guidelines for hypoparathyroidism?
por: Bhadada, Sanjay Kumar, et al.
Publicado: (2012)

Risk of Chronic Kidney Disease in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort
por: Gosmanova, Elvira, et al.
Publicado: (2021)

Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study
por: Ayodele, Olulade, et al.
Publicado: (2022)

Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26‐Week Results From the Phase 3 PaTHway Trial
por: Khan, Aliya A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_576vcb5vhc26fad0m7e2ckprk8